These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 731153)

  • 21. Dopamine receptors on intact anterior pituitary cells in culture: functional association with the inhibition of prolactin and thyrotropin.
    Foord SM; Peters JR; Dieguez C; Scanlon MF; Hall R
    Endocrinology; 1983 May; 112(5):1567-77. PubMed ID: 6832061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-alpha gene expression and growth in anterior pituitary, but not in uterus.
    Borgundvaag B; Kudlow JE; Mueller SG; George SR
    Endocrinology; 1992 Jun; 130(6):3453-8. PubMed ID: 1534540
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacologic evidence that a D2 receptor subtype mediates dopaminergic stimulation of prolactin secretion from the anterior pituitary gland.
    Burris TP; Stringer LC; Freeman ME
    Neuroendocrinology; 1991 Aug; 54(2):175-83. PubMed ID: 1685014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromocriptine and dopamine mediate independent and synergistic apoptotic pathways in pituitary cells.
    Rowther FB; Richardson A; Clayton RN; Farrell WE
    Neuroendocrinology; 2010; 91(3):256-67. PubMed ID: 20110659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis toxin uncouples dopamine agonist inhibition of prolactin release.
    Cronin MJ; Myers GA; MacLeod RM; Hewlett EL
    Am J Physiol; 1983 May; 244(5):E499-504. PubMed ID: 6682634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-specific dopaminergic regulation of the glucocorticoid receptor in the rat pituitary.
    Antakly T; Mercille S; Côté JP
    Endocrinology; 1987 Apr; 120(4):1558-62. PubMed ID: 3830059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The inhibition of phosphatidylinositol turnover: a possible postreceptor mechanism for the prolactin secretion-inhibiting effect of dopamine.
    Canonico PL; Valdenegro CA; MacLeod RM
    Endocrinology; 1983 Jul; 113(1):7-14. PubMed ID: 6861715
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential inhibition of dopamine and bromocriptine on induced prolactin release: multiple sites for the inhibition of dopamine.
    Hanna S; Shin SH
    Neuroendocrinology; 1992 May; 55(5):591-9. PubMed ID: 1316563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear diameter in the anterior pituitary gland of the rat: effects of estrogen, bromocriptine, and haloperidol.
    Jacobi JM; Lloyd HM; Meares JD
    J Histochem Cytochem; 1982 Jul; 30(7):677-81. PubMed ID: 7108194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of the effects of four ergot derivatives on prolactin secretion by dispersed rat pituitary cells.
    Delitala G; Yeo T; Grossman A; Hathway NR; Besser GM
    J Endocrinol; 1980 Oct; 87(1):95-103. PubMed ID: 7430919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antipsychotic drugs inhibit prolactin release from rat anterior pituitary cells in culture by a mechanism not involving the dopamine receptor.
    West B; Dannies PS
    Endocrinology; 1979 Apr; 104(4):877-80. PubMed ID: 436760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of cholinergic receptor blockade and stimulation on the anterior pituitary mitotic activity.
    Pawlikowski M; Stepień H; Wolaniuk A; Kunert-Radek J
    Neuroendocrinology; 1978; 26(2):85-92. PubMed ID: 673147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One minute of bromocriptine irreversibly inhibits prolactin release for hours.
    Cronin MJ; Evans WS; Thorner MO
    Eur J Pharmacol; 1984 Mar; 99(1):85-90. PubMed ID: 6723793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroxine inhibition of the proliferative response of the anterior pituitary to thyrotropin releasing hormone in vitro.
    Pawlikowski M; Stepień H; Kunert-Radek J
    Neuroendocrinology; 1975; 18(3):277-80. PubMed ID: 810736
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biphasic changes in anterior pituitary Met-enkephalin concentration following reserpine treatment.
    George SR; Kertesz M
    Neuroendocrinology; 1988 Feb; 47(2):149-53. PubMed ID: 2830550
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo supersensitivity of the anterior pituitary of old female rats to dopaminergic inhibition of prolactin secretion.
    Cocchi D; Novelli A; Ganzetti I; Müller EE
    Gerontology; 1984; 30(6):345-9. PubMed ID: 6519436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine, dopamine D2 receptor short isoform, transforming growth factor (TGF)-beta1, and TGF-beta type II receptor interact to inhibit the growth of pituitary lactotropes.
    Sarkar DK; Chaturvedi K; Oomizu S; Boyadjieva NI; Chen CP
    Endocrinology; 2005 Oct; 146(10):4179-88. PubMed ID: 15961557
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of thyroidectomy and thyroxine on cell proliferation in the anterior pituitary gland].
    Stepień H
    Endokrynol Pol; 1975; 26(6):613-9. PubMed ID: 1213003
    [No Abstract]   [Full Text] [Related]  

  • 39. The influence of LHRH on the anterior pituitary mitotic activity.
    Pawlikowski M; Kunert-Radek J; Mróz-wasilewska Z; Stepień H
    Endokrynol Pol; 1978; 29(1):1-6. PubMed ID: 348454
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperprolactinemia reduces vasoactive intestinal peptide in the anterior pituitary glands of rats.
    Prysor-Jones RA; Silverlight JJ; Jenkins JS
    Neurosci Lett; 1987 Oct; 80(3):333-8. PubMed ID: 3683988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.